What's New

For latest Government press release, you may visit the HKSAR website.

• Consultation Paper for the Amendment of Schedule 1 and Schedule 2 of the Chinese Medicine Ordinance (Cap. 549) (13 January 2023)

• Recall of Chinese medicine granules contaminated with alkaloids (17 November 2022)

• Recall of Chinese herbal medicine exceeding limit of sulphur dioxide residue (14 November 2022)

• Chinese Medicine Council of Hong Kong Annual Report 2021 Printed edition | Barrier-free version

• Press Release of Department of Health (10 September 2022) : DH investigates poisoning case involving undeclared Western drug ingredient detected in yellowish tablets (with photo)

• Chinese Medicines Traders Newsletter (June 2022) (Chinese version only)
  Printed edition | Barrier-free version

• DH endorses recall of Chinese herbal medicines detected with pesticide residues by licensed Chinese herbal medicines wholesalers (17 May 2022)

• DH takes action to combat illegal sale or possession of unregistered medicines in medicine shops (with photos) (22 February 2022)

• Chinese Medicines Traders Newsletter (December 2021) (Chinese version only)
  Printed edition | Barrier-free version / Appendix 1

• Letter to holders of Wholesaler Licence in Chinese herbal medicines, holders of Retailer Licence in Chinese herbal medicines and holders of Manufacturer Licence in Proprietary Chinese Medicines from the Chinese Medicine Council of Hong Kong on "Amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong"(Chinese version only) (16 December 2021)

• Press Release of Department of Health (25 October 2021) : DH investigates case of undeclared Western drug ingredients detected in cream product prescribed by registered Chinese medicine practitioner (with photo)

• Consultation on amendments to the limits for harmful residues in Chinese herbal medicines and related measures for implementation in Hong Kong

• Press Release of Department of Health (16 September 2021) : DH investigates suspected illegal possession of unregistered proprietary Chinese medicines (with photo)

• Letter to holders of Wholesaler Licence in Chinese herbal medicines, holders of Retailer Licence in Chinese herbal medicines and holders of Manufacturer Licence in Proprietary Chinese Medicines from the Chinese Medicine Council of Hong Kong on "Limits of sulphur dioxide residue in Chinese herbal medicines and revised measures for implementation"(Chinese version only) (27 May 2021)

• Letter to Chinese Medicines traders associations from the Chinese Medicine Council of Hong Kong on "Facilitation measures for conversion of transitional registration of proprietary Chinese medicine to formal registration"(Chinese version only) (15 April 2021)

• Press Release of Department of Health (31 March 2021) : Consultation on amendments to the limits for harmful residues in Chinese herbal medicines in Hong Kong commences